Retroviral vaccines: Challenges for the developing world

[1] ASJO B, 1986, LANCET, V2, P660

[2] PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J]. SCIENCE, 1995, 267 (5205) : 1820 - 1825

[3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4400 - 4408

[4] PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J]. SCIENCE, 1992, 258 (5090) : 1938 - 1941

[5] SIMIAN IMMUNODEFICIENCY VIRUS IN PEOPLE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (03) : 209 - 210

[6] ESSEX M, 1994, TECHNOL REV, V97, P23

[7] Essex M, 1994, Textbook of AIDS medicine, P873

[8] IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1 [J]. SCIENCE, 1991, 253 (5015) : 71 - 74

[9] JAIN MK, 1994, AIDS S2, V8, P561

[10] KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8

[1] ASJO B, 1986, LANCET, V2, P660

[2] PATHOGENICITY OF LIVE, ATTENUATED SIV AFTER MUCOSAL INFECTION OF NEONATAL MACAQUES [J]. SCIENCE, 1995, 267 (5205) : 1820 - 1825

[3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J]. JOURNAL OF VIROLOGY, 1994, 68 (07) : 4400 - 4408

[4] PROTECTIVE EFFECTS OF A LIVE ATTENUATED SIV VACCINE WITH A DELETION IN THE NEF GENE [J]. SCIENCE, 1992, 258 (5090) : 1938 - 1941

[5] SIMIAN IMMUNODEFICIENCY VIRUS IN PEOPLE [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (03) : 209 - 210

[6] ESSEX M, 1994, TECHNOL REV, V97, P23

[7] Essex M, 1994, Textbook of AIDS medicine, P873

[8] IDENTIFICATION OF THE ENVELOPE V3 LOOP AS THE PRIMARY DETERMINANT OF CELL TROPISM IN HIV-1 [J]. SCIENCE, 1991, 253 (5015) : 71 - 74

[9] JAIN MK, 1994, AIDS S2, V8, P561

[10] KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8